Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0166-6851(93)90249-WPMID 8426607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cloning and sequencing of the attachment site and integrase gene of the temperate mycobacteriophage FRAT1.

  1992cited by this paper
• New use of BCG for recombinant vaccines

  1991cited by this paper
• Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

  1991cited by this paper
• Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin.

  1991cited by this paper
• Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.

  1991cited by this paper
• Site‐specific integration of the Streptomyces plasmid pSAM2 in Mycobacterium smegmatis

  1991cited by this paper
• Plasmodium falciparum: recombinant baculoviruses direct the expression of circumsporozoite proteins in Spodoptera frugiperda cell cultures

  1991cited by this paper
• Gene replacement and expression of foreign DNA in mycobacteria

  1990cited by this paper
• Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

  1990cited by this paper
• Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vector

  1990cited by this paper
• Expression of hybrid malaria antigens in insect cells and their engineering for correct folding and secretion

  1990cited by this paper
• An update on candidate malaria vaccines

  1989cited by this paper
• Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

  1989cited by this paper
• Antisporozoite vaccine for malaria: experimental basis and current status.

  1989cited by this paper
• Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum

  1988cited by this paper
• Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

  1988cited by this paper
• Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum.

  1988cited by this paper
• Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

  1987cited by this paper
• Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12

  1987cited by this paper
• Characterization, Sequence Determination, and Immunogenicity of a 64-Kilodalton Protein of Mycobacterium bovis BCG Expressed in Escherichia coli K-12

  1987cited by this paper
• Introduction of foreign DNA into mycobacteria using a shuttle phasmid

  1987cited by this paper
• Development of a sporozoite malaria vaccine.

  1986cited by this paper
• Research toward malaria vaccines.

  1986cited by this paper
• Vectors with restriction site banks IV. pJRD184, a 3793-bp plasmid vector having 43 unique cloning sites

  1985cited by this paper
• Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.

  1985cited by this paper
• Total DNA synthesis and cloning in Escherichia coli of a gene coding for the human growth hormone releasing factor.

  1985cited by this paper
• Vectors with restriction site banks. IV. pJRD184, a 3793-bp plasmid vector with 49 unique restriction sites.

  1985cited by this paper
• Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

  1984cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice.

  1977cited by this paper
• Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

  1975cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• Media and methods for phage-typing mycobacteria.

  1966cited by this paper

• A Review on Mycobacteriophages: From Classification to Applications

  2022influential citation
• Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes

  2017cites this paper
• Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors

  2015cites this paper
• Expressão de antígenos de Schistosoma mansoni em BCG recombinante

  2013cites this paper
• CLONING AND EXPRESSION OF MALARIA AND TUBERCULOSIS EPITOPES IN MYCOBACTERIUM BOVIS

  2011cites this paper
• New Generation BCG Vaccines

  2011cites this paper
• Challenges and perspectives in vaccination against leishmaniasis.

  2009cites this paper
• Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria.

  2009cites this paper
• Efficient point mutagenesis in mycobacteria using single‐stranded DNA recombineering: characterization of antimycobacterial drug targets

  2008cites this paper
• Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.

  2007cites this paper
• Cloning and expression of malaria and tuberculosis epitopes in mycobacterium bovis bacille calmette-guérin.

  2006cites this paper
• Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes.

  2006cites this paper
• Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge.

  2006cites this paper
• Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

  2005cites this paper
• Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines.

  2005cites this paper
• Mycobacteriophages: Pathogenesis and Applications

  2005cites this paper
• Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate

  2005cites this paper
• A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability.

  2003cites this paper
• Recombinant BCG vaccines.

  2001cites this paper
• Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice.

  2001cites this paper
• Induction of Neutralizing Antibodies against Diphtheria Toxin by Priming with Recombinant Mycobacterium bovis BCG Expressing CRM197, a Mutant Diphtheria Toxin

  2001cites this paper
• Mycobacterium bovis BCG recADeletion Mutant Shows Increased Susceptibility to DNA-Damaging Agents but Wild-Type Survival in a Mouse Infection Model

  2001cites this paper
• 9 Genetic Methods in Mycobacteria

  1999cites this paper
• 3 Exploitation of Bacteriophages and their Components

  1999cites this paper
• The use of assembly polymerase chain reaction for cloning of a malarial epitope into Mycobacterium smegmatis – importance of overcoming codon bias

  1999cites this paper
• Molecular Biology of Mycobacterium Tuberculosis

  1998cites this paper
• Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Secreting Merozoite Surface Protein 1 (MSP1) Induces Protection against Rodent Malaria Parasite Infection Depending on MSP1-stimulated Interferon γ and Parasite-specific Antibodies

  1998cites this paper
• Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.

  1998cites this paper
• The genetic reconstruction of BCG as a new immunotherapeutic tool.

  1997cites this paper
• The molecular genetics of Mycobacterium tuberculosis.

  1996cites this paper
• A stable Escherichia coli-mycobacteria shuttle vector 'pSO246' in Mycobacterium bovis BCG.

  1996cites this paper
• Stable expression and secretion of the B-cell epitope of rodent malaria from Mycobacterium bovis BCG and induction of long-lasting humoral response in mouse.

  1996cites this paper
• A stableEscherichia coli-mycobacteria shuttle vector âpSO246â inMycobacterium bovisBCG

  1996cites this paper
• Analysis of the Mycobacterium tuberculosis 85A antigen promoter region

  1995cites this paper
• and C 85 A antigen promoter region . Analysis of the Mycobacterium tuberculosis

  1995cites this paper
• rpsL+: a dominant selectable marker for gene replacement in mycobacteria

  1995cites this paper
• Mycobacterium: isolation, maintenance, transformation, and mutant selection.

  1994cites this paper
• Mycobacterium: isolation, maintenance, transformation, and mutant selection.

  1994cites this paper
• Structural instability of recombinant plasmids in mycobacteria.

  1994cites this paper
• Genetic transformation of mycobacteria.

  1993cites this paper